Диссертация (1145983), страница 37
Текст из файла (страница 37)
Higgins, E. K. Moses [et al.] // Obstet Gynecol. - 2010. - Vol. 115, №1. - P. 5-13.260. Salonen, R. H. Genetic effects on the liability of developing pre-eclampsia and gestationalhypertension / R. H. Salonen, P. Lichtenstein, L. Lipworth, S. Cnattingius // Am J Med Genet. 2000. - Vol. 91, № 4.
- P. 256-260.261. Sambrook, J. Molecular cloning: a laboratory manual / J. Sambrook, E. P. Fritsch, T. Maniatis- NY. : Cold Spring Harbor Laboratory Press, 1989. -1885 p.262. Sandrim,V. C. Effects of eNOS polymorphisms on nitric oxide formation in healthypregnancy and in pre-eclampsia / V. C. Sandrim, A. C. Palei, J. T. Sertorio // Mol Hum Reprod.- 2010. - Vol. 16, № 7. - P. 506-510.263. Savarimuthu Francis, S. M.
MicroRNA-34c is associated with emphysema severity andmodulates SERPINE1 expression / S. M. Savarimuthu Francis, M. R. Davidson, M. E. Tan [etal.] // BMC Genomics. - 2014. - Vol. 15: 88. - 8 p.264. Schierer, A. Genetic variation in cholesterol ester transfer protein, serum CETP activity, andcoronary artery disease risk in Asian Indian diabetic cohort / A.
Schierer, L. F. Been, S. Ralhan[et al.] // Pharmacogenet Genomics. - 2012. - Vol. 22, № 2. - P. 95-104.265. Seasholtz, T. M. Rho kinase polymorphism influences blood pressure and systemic vascularresistance in human twins: role of heredity / T. M. Seasholtz, J. Wessel, F. Rao [et al.] //Hypertension. - 2006. - Vol. 47, № 5. - P. 937-947.266. Seremak-Mrozikiewicz, A. A1166C mutation of angiotensin II type 1 receptor gene iscorrelated with umbilical blood flow velocimetry in women with preeclampsia / A. SeremakMrozikiewicz, M. Dubiel, K. Drews [et al.] // J Matern Fetal Neonatal Med. - 2005. - Vol.
17,№ 2. - P. 117-121.267. Seremak-Mrozikiewicz, A. Gestational hypertension (GH) and a1166c polymorphism ofangiotensin II type 1 receptor [Abstract] / A. Seremak-Mrozikiewicz, K. Drews, E. Chmara [etal.] // Ginekol Pol. - 2000. - Vol. 71, № 8. - P. 783-788.150268. Seremak-Mrozikiewicz, A. The significance of −786T > C polymorphism of endothelial NOsynthase (eNOS) gene in severe preeclampsia / A. Seremak-Mrozikiewicz, K. Drews, M. Barlik[et al.] // J Matern Fetal Neonatal Med.
- 2011a. - Vol. 24, № 3. - P. 432-436.269. Seremak-Mrozikiewicz, A. The significance of genetic polymorphisms of factor v leiden andprothrombin in the preeclamptic polish women / A. Seremak-Mrozikiewicz, K. Drews, E.Wender-Ozegowska, P. M. Mrozikiewicz // J Thromb Thrombolysis. - 2010. - Vol. 30, № 1. - P.97-104.270. Serrano, N. C. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter casecontrol study / N. C.Serrano, J. P. Casas, L. A. Diaz [et al.] // Hypertension. - 2004.
- Vol. 44,№ 5. - P. 702-707.271.Serum levels of lipids, lipoproteins and paraoxonase activity in pre-eclampsia / B. Demir, S.Demir, Y. Atamer [et al.] // J Int Med Res. - 2011. - Vol. 39, № 4. - P. 1427-1431.272. Sethupathy, P. Human microRNA-155 on chromosome 21 differentially interacts with itspolymorphic target in the AGTR1 3' untranslated region: a mechanism for functional singlenucleotide polymorphisms related to phenotypes / P. Sethupathy, C. Borel, M. Gagnebin [et al.]// Am J Hum Genet. - 2007. - Vol.
81, № 2. - P. 405-413.273.Shah, V. N. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk ofnephropathy in Asian Indian patients with type 2 diabetes / V. N. Shah, B. S. Cheema, R.Sharma [et al.] // Mol Cell Biochem. - 2013. - Vol. 372, № 1-2. - P. 191-198.274. Shanker, J. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with prematurecoronary artery disease / J. Shanker, G.
Perumal, V. S. Rao et al. // Lipids Health Dis. -2008. Vol. 7: 33. - 14 p.275. Skjaerven, R. Recurrence of pre-eclampsia across generations: exploring fetal and maternalgenetic components in a population based cohort / R. Skjaerven, L. J. Vatten, A. J. Wilcox [etal.] // BMJ. - 2005. - Vol. 331, № 7521: 877. - 5 p.276. Slaby, O.
MicroRNAs in colorectal cancer: translation of molecular biology into clinicalapplication / O. Slaby, M. Svoboda, J. Michalek, R. Vyzula // Mol Cancer. - 2009. - Vol. 8: 102.- 13 p.277.Snieder, H. Beta2-adrenergic receptor gene and resting hemodynamics in European andAfrican American youth / H. Snieder, Y. Dong, P.
Barbeau [et al.] // Am J Hypertens. - 2002.Vol. 15, № 11. - P. 973-979.278. Sohda, S. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia / S. Sohda, T.Arinami, H. Hamada [et al.] // J Med Genet. - 1997. - Vol. 34, № 6. - P. 525-526.279. Solaas, K. Suggestive evidence of associations between liver X receptor beta polymorphismswith type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA151(France) and HELENA (Europe) / K. Solaas, V.
Legry, K. Retterstol [et al.] // BMC Med Genet.- 2010. - Vol. 11: 144. - 11 p.280. Staines-Urias, E. Genetic association studies in pre-eclampsia: systematic meta-analyses andfield synopsis / E. Staines-Urias, M. C. Paez, P. Doyle [et al.] // Int J Epidemiol. - 2012. - Vol.41, № 6. - P. 1764-1775.281. Steegers, E. A. Pre-eclampsia / E.
A. Steegers, P. von Dadelszen, J. J. Duvekot, R. Pijnenborg// The Lancet. - 2010. Vol. 376, № 9741. - P. 631-644.282.Sun, Z. CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data / Z.Sun, J. Evans, A. Bhagwate [et al.] // BMC Genomics. - 2014. - Vol. 15: 423. - 10 p.Suppl B:.283. Sutherland, A. The indicence of severe preeclampsia amongst mothers and mothers-in-law ofpreeclamptics and controls / A.
Sutherland, D. W. Cooper, P. W. Howie [et al.] // Br J ObstetGynaecol. - 1981. - Vol. 88, № 8. - P. 785-791.284.Tang, W. W. A unique gene regulatory network resets the hman germline epigenome fordevelopment / W. W. Tang, S. Dietmann, N. Irie [et al.] // Cell. - 2015. - Vol. 161, № 6. - P.1453-1467.285.Tempfer, C. B. An endothelial nitric oxide synthase gene polymorphism is associated withpreeclampsia / C. B. Tempfer, K.
Dorman, R. L. Deter [et al.] // Hypertens Pregnancy. - 2001. Vol. 20, № 1. - P. 107-118.286. Tempfer, C. B. Polymorphisms of thrombophilic and vasoactive genes and severepreeclampsia:a pilot study / C. B. Tempfer, S. Jirecek, E. K. Riener [et al.] // J Soc GynecolInvestig.
- 2004. - Vol. 11, № 4. - P. 227-231.287.Teng, Y. C. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the roleof placental trophoblasts / Y. C .Teng, Q. D. Lin, J. H. Lin [et al.] // J Perinat Med. – 2009. ─Vol. 37, № 4. ─ P. 343–348.288. Tenhola, S. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children:evaluation by ambulatory blood pressure monitoring / S. Tenhola, E. Rahiala, P. Halonen [et al.]// Pediatr Res. - 2006. - Vol. 59, № 2. - P.
320-324.289.Thornton J. G. Pre-eclampsia: discordance among identical twins / J. G. Thornton, J. L.Onwude // BMJ. - 1991. - Vol. 303, № 6812. - P. 1241-1242.290.Thornton J. G. Twin mothers, pregnancy hypertension and pre-eclampsia / J. G. Thornton, A.M. Macdonald // Br J Obstet Gynaecol. - 1999. - Vol. 106, № 6. - P. 570-575.291.Ticconi, C. Beta-fibrinogen G-455A polymorphisms and recurrent miscarriage / C. Ticconi, F.Mancinelli, P. Gravina [et al.] // Gynecol Obstet Invest.
- 2011. - Vol. 71, № 3. - P. 198-201.152292. Tomaszewski, M. Essential hypertension and beta2-adrenergic receptor gene: linkage andassociation analysis / M. Tomaszewski, N. J. Brain, F. J. Charchar [et al.] // Hypertension. 2002. - Vol. 40, № 3. - P. 286-291.293. Tosun, M. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumornecrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia /M.
Tosun, H. Celik, B. Avci [et al.] // J Matern Fetal Neonatal Med. - 2010. - Vol. 23, № 8. - P.880-886.294.Treloar, S. A. An Australian twin study of the genetic basis of preeclampsia and eclampsia / S.A. Treloar, D. W. Cooper, S. P. Brennecke [et al.] // Am J Obstet Gynecol. - 2001. - Vol. 184,№ 3. - P. 374-381.295. Tsai, K.
W. Epigenetic control of the expression of a primate-specific microRNA cluster inhuman cancer cells / K. W. Tsai, H. W. Kao, H. C. Chen [et al.] // Epigenetics. - 2009. - Vol. 4,№ 8. - P. 587-592.296.Turgut, S. Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166gene polymorphisms in patients with acromegaly / S. Turgut, F. Akın, R. Akcılar [et al.] // MolBiol Rep. - 2011. - Vol.
38, № 1. - P. 569-576.297.van Empel V. P. Circulating miRNAs: reflecting or affecting cardiovascular disease? // V. P.van Empel, L. J. De Windt, P. A. da Costa Martins // Curr Hypertens Rep. - 2012. - Vol. 14, №6. - P. 498-509.298. van Rijn, M. J. Polymorphisms of the rennin-angiotensin system are associated with bloodpressure, atherosclerosis and cerebral white matter pathology / M. J. van Rijn, M. J. Bos, A.Isaacs [et al.] // J Neurol Neurosurg Psychiatry. - 2007. - Vol. 78, № 10. - P. 1083-1087.299.Vashukova, E.
S. Placental microRNA expression in pregnancies complicated by superimposedpre-eclampsia on chronic hypertension / E. S. Vashukova, A. S. Glotov, P. V. Fedotov [et al.] //Molecular Medicine Reports. – 2016. - Vol. 14, № 1. - P. 22-32.300. Vefring, H. Maternal and fetal variants of genetic thrombophilias and the risk of preeclampsia/ H. Vefring, R.T. Lie, R. Degard [et al.] // Epidemiology. - 2004. - Vol. 15, № 3. - P. 317-322.301.Veldman, B. A.
The Glu298Asp polymorphism of the NOS3 gene as a determinant of thebaseline production of nitric oxide / B. A. Veldman, W. Spiering, P. A. Doevendans [et al.] // JHypertens. - 2002. - Vol. 20, № 10. - P. 2023-2027.302. Verin, A. D. Regulation of endothelial cell gap formation and barrier function by myosinassociated phosphatase activities / A. D. Verin, C. E. Patterson, M. A. Day, J.
G. Garcia / Am JPhysiol. - 1995. - Vol. 269, № 1 Pt 1. - P. L99-L108.303. von Tempelhoff, G. F. Incidence of the factor V leiden-mutation, coagulation inhibitordeficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP–153syndrome / G.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
